Comparing Viberzi vs Xifaxan
| Viberzi (eluxadoline) | Xifaxan (rifaximin) |
|
|---|
| Viberzi (eluxadoline) | Xifaxan (rifaximin) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Irritable Bowel Syndrome with Diarrhea, Diarrhea, Irritable Bowel Syndrome. Viberzi may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Hepatic Encephalopathy, Irritable Bowel Syndrome with Diarrhea, Irritable Bowel Syndrome, Traveler's Diarrhea, Diarrhea. Xifaxan may also be used for purposes not listed in this... View more |
Related suggestions Irritable Bowel Syndrome
Irritable Bowel Syndrome with Diarrhea
|
|||||||||||||||
| More about Viberzi (eluxadoline) | More about Xifaxan (rifaximin) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Viberzi has an average rating of 6.7 out of 10 from a total of 217 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 25% reported a negative effect. |
Xifaxan has an average rating of 6.6 out of 10 from a total of 97 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 34% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Viberzi side effects |
View all Xifaxan side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Viberzi prices |
View all Xifaxan prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
6 hours |
10.19 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 214 drugs are known to interact with Viberzi:
|
A total of 92 drugs are known to interact with Xifaxan:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
May 27, 2015 |
May 25, 2004 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.